EVOLENT HEALTH INC - A (EVH) Stock Fundamental Analysis

NYSE:EVH • US30050B1017

2.79 USD
+0.15 (+5.68%)
At close: Feb 13, 2026
2.79 USD
0 (0%)
After Hours: 2/13/2026, 8:05:44 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall EVH gets a fundamental rating of 2 out of 10. We evaluated EVH against 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of EVH have multiple concerns. While showing a medium growth rate, EVH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • EVH had negative earnings in the past year.
  • In the past year EVH has reported a negative cash flow from operations.
  • In the past 5 years EVH always reported negative net income.
  • In multiple years EVH reported negative operating cash flow during the last 5 years.
EVH Yearly Net Income VS EBIT VS OCF VS FCFEVH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -7.37%, EVH is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
  • With a decent Return On Equity value of -21.48%, EVH is doing good in the industry, outperforming 62.86% of the companies in the same industry.
  • With a Return On Invested Capital value of 0.68%, EVH perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
ROA -7.37%
ROE -21.48%
ROIC 0.68%
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
EVH Yearly ROA, ROE, ROICEVH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

1.3 Margins

  • EVH has a better Operating Margin (0.86%) than 65.71% of its industry peers.
  • EVH has a Gross Margin of 18.42%. This is amonst the worse of the industry: EVH underperforms 85.71% of its industry peers.
  • In the last couple of years the Gross Margin of EVH has declined.
Industry RankSector Rank
OM 0.86%
PM (TTM) N/A
GM 18.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
EVH Yearly Profit, Operating, Gross MarginsEVH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • EVH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • EVH has more shares outstanding than it did 1 year ago.
  • EVH has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, EVH has a worse debt to assets ratio.
EVH Yearly Shares OutstandingEVH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EVH Yearly Total Debt VS Total AssetsEVH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 0.54, we must say that EVH is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.54, EVH is in line with its industry, outperforming 54.29% of the companies in the same industry.
  • EVH has a Debt/Equity ratio of 1.26. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.26, EVH is doing worse than 88.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF N/A
Altman-Z 0.54
ROIC/WACC0.1
WACC6.87%
EVH Yearly LT Debt VS Equity VS FCFEVH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.33 indicates that EVH should not have too much problems paying its short term obligations.
  • EVH has a Current ratio of 1.33. This is in the lower half of the industry: EVH underperforms 65.71% of its industry peers.
  • A Quick Ratio of 1.33 indicates that EVH should not have too much problems paying its short term obligations.
  • EVH's Quick ratio of 1.33 is on the low side compared to the rest of the industry. EVH is outperformed by 65.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.33
EVH Yearly Current Assets VS Current LiabilitesEVH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • EVH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -101.10%.
  • The Earnings Per Share has been growing by 220.75% on average over the past years. This is a very strong growth
  • EVH shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.65%.
  • Measured over the past years, EVH shows a very strong growth in Revenue. The Revenue has been growing by 30.04% on average per year.
EPS 1Y (TTM)-101.1%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)-16.65%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-22.83%

3.2 Future

  • Based on estimates for the next years, EVH will show a small growth in Earnings Per Share. The EPS will grow by 8.00% on average per year.
  • Based on estimates for the next years, EVH will show a small growth in Revenue. The Revenue will grow by 6.65% on average per year.
EPS Next Y-88.92%
EPS Next 2Y-27.05%
EPS Next 3Y-7.07%
EPS Next 5Y8%
Revenue Next Year-26.73%
Revenue Next 2Y-3.58%
Revenue Next 3Y1.67%
Revenue Next 5Y6.65%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EVH Yearly Revenue VS EstimatesEVH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B
EVH Yearly EPS VS EstimatesEVH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EVH. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 7.94 indicates a rather cheap valuation of EVH.
  • EVH's Price/Forward Earnings ratio is rather cheap when compared to the industry. EVH is cheaper than 91.43% of the companies in the same industry.
  • EVH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.06.
Industry RankSector Rank
PE N/A
Fwd PE 7.94
EVH Price Earnings VS Forward Price EarningsEVH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EVH is valued a bit cheaper than the industry average as 77.14% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.62
EVH Per share dataEVH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • EVH's earnings are expected to decrease with -7.07% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.05%
EPS Next 3Y-7.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for EVH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EVOLENT HEALTH INC - A

NYSE:EVH (2/13/2026, 8:05:44 PM)

After market: 2.79 0 (0%)

2.79

+0.15 (+5.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06
Earnings (Next)02-24
Inst Owners124.12%
Inst Owner Change-6.62%
Ins Owners1.56%
Ins Owner Change3.93%
Market Cap311.36M
Revenue(TTM)2.05B
Net Income(TTM)-180.88M
Analysts84
Price Target9.33 (234.41%)
Short Float %17.44%
Short Ratio5.89
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-139.54%
Min EPS beat(2)-226.45%
Max EPS beat(2)-52.63%
EPS beat(4)0
Avg EPS beat(4)-162.45%
Min EPS beat(4)-332.96%
Max EPS beat(4)-37.77%
EPS beat(8)3
Avg EPS beat(8)-78.52%
EPS beat(12)6
Avg EPS beat(12)-25.77%
EPS beat(16)10
Avg EPS beat(16)442.42%
Revenue beat(2)1
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-4.24%
Max Revenue beat(2)1.56%
Revenue beat(4)2
Avg Revenue beat(4)-0.09%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)4.03%
Revenue beat(8)5
Avg Revenue beat(8)0.67%
Revenue beat(12)7
Avg Revenue beat(12)0.38%
Revenue beat(16)10
Avg Revenue beat(16)1.03%
PT rev (1m)-10.18%
PT rev (3m)-41.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-52.15%
EPS NY rev (1m)-0.73%
EPS NY rev (3m)-70.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.94
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B 0.37
P/tB N/A
EV/EBITDA 10.62
EPS(TTM)-0.01
EYN/A
EPS(NY)0.35
Fwd EY12.59%
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS18.41
BVpS7.55
TBVpS-7.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.37%
ROE -21.48%
ROCE 0.87%
ROIC 0.68%
ROICexc 0.73%
ROICexgc 6.52%
OM 0.86%
PM (TTM) N/A
GM 18.42%
FCFM N/A
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
F-Score4
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF N/A
Debt/EBITDA 9.01
Cap/Depr 32.44%
Cap/Sales 1.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.33
Altman-Z 0.54
F-Score4
WACC6.87%
ROIC/WACC0.1
Cap/Depr(3y)38.35%
Cap/Depr(5y)41.66%
Cap/Sales(3y)1.98%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-101.1%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y-88.92%
EPS Next 2Y-27.05%
EPS Next 3Y-7.07%
EPS Next 5Y8%
Revenue 1Y (TTM)-16.65%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-22.83%
Revenue Next Year-26.73%
Revenue Next 2Y-3.58%
Revenue Next 3Y1.67%
Revenue Next 5Y6.65%
EBIT growth 1Y218.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year297.48%
EBIT Next 3Y70.85%
EBIT Next 5Y48.16%
FCF growth 1Y-223.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-140.71%
OCF growth 3Y-21.47%
OCF growth 5YN/A

EVOLENT HEALTH INC - A / EVH FAQ

What is the fundamental rating for EVH stock?

ChartMill assigns a fundamental rating of 2 / 10 to EVH.


Can you provide the valuation status for EVOLENT HEALTH INC - A?

ChartMill assigns a valuation rating of 3 / 10 to EVOLENT HEALTH INC - A (EVH). This can be considered as Overvalued.


Can you provide the profitability details for EVOLENT HEALTH INC - A?

EVOLENT HEALTH INC - A (EVH) has a profitability rating of 2 / 10.


Can you provide the financial health for EVH stock?

The financial health rating of EVOLENT HEALTH INC - A (EVH) is 1 / 10.